Category: CBD Stocks
SFWJ / Medcana Announces Successful Export of First CBD Crop
AUSTIN, TEXAS / ACCESS Newswire / April 2, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana,…

CBD of Denver Achieves 26% Revenue Growth and Returns to Positive Operating Income in 2024
CBD of Denver, Inc. (OTC Pink: CBDD), a diversified holding company, today announced key financial highlights for the fiscal year…

New Study Reveals Dramatic Generational Shifts in CBD Usage and Wellness Priorities
A groundbreaking study by CBDistillery has uncovered significant generational differences in how Americans approach CBD use and wellness, highlighting an…
InnoCan Pharma And 2 Other TSX Penny Stocks With Growth Potential
As the Canadian market navigates trade uncertainties and inflation concerns, investors are seeking opportunities that balance growth potential with resilience….
Short Interest in CBD of Denver Inc. (OTCMKTS:CBDD) Rises By 87.4%
CBD of Denver Inc. (OTCMKTS:CBDD – Get Free Report) saw a large increase in short interest in March. As of…

OOKA Expands Offerings with the Launch of Pacific Realms CBD Pods in the United States
OOKA, manufactured and distributed by Advanced Inhalation Rituals (AIR), is proud to announce the launch of Pacific Realms CBD Pods…

CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex – A Powerful Sexual Enhancement Supplement
The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth…

U.S. Hemp Roundtable Partners with BlueCheck to Elevate Age Verification for Hemp & CBD Businesses
BlueCheck & U.S. Hemp Roundtable Announce Partnership …
CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025
CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona’s Hottest Motorcycle Event SCOTTSDALE, AZ…
180 Life Sciences (NASDAQ:ATNF) Given Sell (E+) Rating at Weiss Ratings
Life Sciences (NASDAQ:ATNF – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by equities researchers at Weiss Ratings…
Recent Comments